Variant report
Variant | esv3421281 |
---|---|
Chromosome Location | chr13:38686001-38716773 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr13:38697528..38699053-chr13:38760202..38763046,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs547848366 | chr13:38693214-38693215 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs9532171 | chr13:38693258-38693259 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs578232578 | chr13:38693273-38693274 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs545901447 | chr13:38693371-38693372 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs562610111 | chr13:38693375-38693376 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs575941531 | chr13:38693410-38693411 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs7319078 | chr13:38693417-38693418 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs147371023 | chr13:38693457-38693458 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs114280371 | chr13:38693534-38693535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs547161206 | chr13:38693544-38693545 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs191109382 | chr13:38693600-38693601 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs565446840 | chr13:38695212-38695213 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs530118293 | chr13:38695221-38695222 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs532832179 | chr13:38695281-38695282 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs534284237 | chr13:38695349-38695350 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs11334801 | chr13:38695366-38695367 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs143041501 | chr13:38695380-38695381 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs375139043 | chr13:38695395-38695396 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs369635298 | chr13:38695431-38695432 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs113901552 | chr13:38695498-38695499 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs543683681 | chr13:38695523-38695524 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs557012741 | chr13:38695535-38695536 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs141132188 | chr13:38695550-38695551 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs542464040 | chr13:38695558-38695559 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs536930956 | chr13:38695573-38695574 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs559760936 | chr13:38695596-38695597 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs35767431 | chr13:38695599-38695600 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs528614959 | chr13:38695600-38695601 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs545394402 | chr13:38695632-38695633 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs1924192 | chr13:38695683-38695684 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
31 | rs376489886 | chr13:38695788-38695789 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs9532172 | chr13:38695842-38695843 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs552661073 | chr13:38695942-38695943 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs551247709 | chr13:38695990-38695991 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs147380399 | chr13:38696011-38696012 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs530273671 | chr13:38696016-38696017 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs546892335 | chr13:38696062-38696063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs138807858 | chr13:38696078-38696079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs372813448 | chr13:38696081-38696082 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs139507371 | chr13:38696102-38696103 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs534389603 | chr13:38696133-38696134 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs143259572 | chr13:38696154-38696155 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs570898430 | chr13:38696174-38696175 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs373644056 | chr13:38696177-38696178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs541471935 | chr13:38696205-38696206 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs147507374 | chr13:38696221-38696222 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs139429850 | chr13:38696248-38696249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs553228274 | chr13:38696290-38696291 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs191990324 | chr13:38696318-38696319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs114500056 | chr13:38696345-38696346 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 20164920 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17899364 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Trisomy | 24170809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Alveolar rhabdomyosarcoma | 16790082 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 18632612 | CNVD |
Prostate cancer | 21965145 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Monoclonal gammopathy of undetermined significance | 19135901 | CNVD |
Prostate cancer | 19242612 | CNVD |
Prostate cancer | 17245344 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Developmental delay | 21147756 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Melanoma | 18172304 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:38693200-38693600 | Enhancers | Primary B cells from peripheral blood | blood |
2 | chr13:38695200-38695600 | Active TSS | Pancreatic Islets | Pancreatic Islet |
3 | chr13:38695600-38697000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
4 | chr13:38704200-38708200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr13:38709600-38710400 | Enhancers | Muscle Satellite Cultured Cells | -- |
6 | chr13:38710400-38715600 | Weak transcription | Muscle Satellite Cultured Cells | -- |
7 | chr13:38715000-38716400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr13:38715400-38726200 | Weak transcription | Pancreas | Pancrea |
9 | chr13:38715600-38716400 | Enhancers | HUVEC | blood vessel |
10 | chr13:38715600-38716600 | Enhancers | Muscle Satellite Cultured Cells | -- |
11 | chr13:38716600-38717200 | Enhancers | Ovary | ovary |
12 | chr13:38716600-38718200 | Weak transcription | Muscle Satellite Cultured Cells | -- |